We have located links that may give you full text access.
Comparative Study
Journal Article
Thirty-Day Readmission Rates Comparing Specific Cruciate Retaining and Posterior Stabilizing Knee Arthroplasties to the National Readmission Rates.
Unplanned hospital readmissions within 30 days of surgery result in reimbursement penalties following total knee arthroplasty (TKA). Therefore, evaluating current readmission rates and comparing these to national levels is one way to self-assess and determine possible areas where improvements can be made. In this study, the 30-day readmission data for 845 TKAs performed with a single prosthesis were compared to the readmission data from the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) Database of 12,035 TKAs. We determined this following: (1) whether the TKA groups readmission rates were comparable; (2) the similarities and differences between readmission causes between the cohorts; and (3) the patient factors associated with increased readmission rates. The 30-day readmission rate for our cohort was lower than the NSQIP rate (2.1% versus 4.3%, respectively). Among all readmissions, our database had fewer readmissions due to surgically related complications (44% versus 57%, respectively). Patients in the single-prosthesis database had higher body mass indexes and higher rates of cardiovascular disorders, diabetes, and musculoskeletal disease. Within the NSQIP cohort, a higher proportion of males than females were readmitted. The most common comorbidities in the readmitted cohort were diabetes, chronic obstructive pulmonary disease, cardiac surgery, hypertension, bleeding disorders, and American Society of Anesthesiologists (ASA) grade 3. Of the surgically related factors, readmitted patients had significantly longer operative procedures. The 30-day readmission rate for patients undergoing primary TKAs in our database was lower than that of a national database.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app